Wait a few moments, please...  Wait a few moments, please...
    
Metadata (Opens new window)Get table previously savedSave tableDownload Chart (JPEG, PNG or PDF format)Conventional signs (Opens new window)

Place of residence (NUTS II - 1999) (1) Vaccination coverage to individuals who complete 1 year of age (2017 - %) by Place of residence (NUTS II - 1999) and Type of administrated vaccine; Annual (3)
Data reference period (2)
2021
Type of administrated vaccine
BCG: Vaccine against TBVBH3: Vaccine against hepatitis B (3rd inoculations)Hib3: Vaccine against invasive disease caused by Haemophilus influenzae (3rd inoculations)Pn132: Conjugate vaccine against infections by Streptococcus pneumoniae of 13 serotypes (2nd inoculations)Dif3: Vaccine against diphteria (3rd inoculations)Tet3: Vaccine against tetanus (3rd inoculations)Tcp3: Vaccine against whooping cough/pertussis (3rd inoculations)VIP3: Injectable inactivated vaccine against polio (3rd inoculations)MenB2: Vaccine against invasive disease caused by Neisseria meningitidis B (2nd inoculations)
% % % % % % % % %
PT: Portugalx98,698,698,998,698,698,698,697,7
1: Continentex98,698,698,998,698,698,698,697,7
2: Região Autónoma dos Açoresx97,997,998,697,997,997,997,996,3
3: Região Autónoma da Madeirax98,998,999,598,998,998,998,998,7
Vaccination coverage to individuals who complete 1 year of age (2017 - %) by Place of residence (NUTS II - 1999) and Type of administrated vaccine; Annual - Directorate-General of Health
Note(s):
(1) From 2017 onwards, vaccine coverage will be made available by vaccine against a disease, not by monovalent or combined vaccine;
(2) These values are in accordance with the recommended scheme.
(3) Since 2016, BCG vaccine is recommended only for at-risk groups.

This data last updated:march 03, 2023